Evaluating the safety of {beta}-interferons in MS: A series of nested case-control studies

Conclusions:
Among patients with RRMS, IFN-β was associated with a 1.8- and 1.6-fold increase in the risk of stroke and migraine and 1.3-fold increases in depression and hematologic abnormalities.

Source: Neurology - June 12, 2017 Category: Neurology Authors: de Jong, H. J. I., Kingwell, E., Shirani, A., Cohen Tervaert, J. W., Hupperts, R., Zhao, Y., Zhu, F., Evans, C., van der Kop, M. L., Traboulsee, A., Gustafson, P., Petkau, J., Marrie, R. A., Tremlett, H., On behalf of the British Columbia Multiple Scleros Tags: Patient safety, Multiple sclerosis, All epidemiology, Case control studies ARTICLE Source Type: research